XML 39 R15.htm IDEA: XBRL DOCUMENT v3.19.3
Employee Benefit Plans
9 Months Ended
Sep. 30, 2019
Compensation Related Costs [Abstract]  
Employee Benefit Plans

7. Employee Benefit Plans

Equity Incentive Plans

The Company has two equity incentive plans: the 2011 Equity Incentive Plan (the “2011 Plan”) and the 2018 Equity Incentive Plan (the “2018 Plan”). To the extent that grants outstanding under the 2011 Plan terminate, cancel or are forfeited, the shares reserved for issuance under such grants are automatically transferred to the 2018 Plan and become available for subsequent grant thereunder.

Under the 2018 Plan, the Board or a committee of the Board, may grant incentive and nonqualified stock options, stock appreciation rights, restricted or unrestricted stock awards, restricted stock units (“RSUs”), phantom stock, performance awards or other stock-based awards to employees, directors and other individuals providing services to the Company. The purpose of the 2018 Plan is to promote the long-term growth and profitability of the Company by (i) providing employees with incentives to improve stockholder value and to contribute to the growth and financial success of the Company through their future services, and (ii) enabling the Company to attract, retain and reward the best‑available persons. The options granted under the 2018 Plan, may be granted at a price not less than the fair market value on the grant date.

The Board, or a committee of the Board, has granted options with an exercise price at or which approximates the fair value on the grant date to new hires, except for the out-of-the-money options granted to certain employees as discussed below. Grants of time-based awards generally vest over a four-year period for new hires and over a three-year period for subsequent grants to existing employees. The service condition for the majority of these awards is satisfied generally over the applicable vesting period. Options expire as determined by the Board, or committee of the Board, but not more than ten years after the date of the grant. In the second quarter of 2015, the Company began granting restricted stock units that contain both a service condition and Performance Vesting Condition. Both the service condition and Performance Vesting Condition must be met in order for these awards to vest and issue. The Performance Vesting Condition occurred upon the effectiveness of the registration statement for the Company's IPO, which was September 25, 2018.

As of September 30, 2019, 8,371,369 shares of common stock remain available for grant under the 2018 Plan.

The following is a summary of stock option activity for the current year period:

 

 

 

Stock Options

 

 

 

Number of

Shares

 

 

Weighted

Average

Exercise

Price

 

 

Aggregate

Intrinsic Value

(in thousands)

 

 

Weighted

Average

Remaining

Contractual

Term

(in years)

 

Outstanding at December 31, 2018

 

 

18,452,375

 

 

$

14.39

 

 

$

8,482

 

 

 

7.5

 

Granted

 

 

3,128,591

 

 

$

13.95

 

 

 

 

 

 

 

 

 

Exercised

 

 

(3,319,196

)

 

$

12.65

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(1,240,835

)

 

$

14.05

 

 

 

 

 

 

 

 

 

Expired

 

 

(934,413

)

 

$

15.88

 

 

 

 

 

 

 

 

 

Outstanding, vested and expected to vest at September 30, 2019

 

 

16,086,522

 

 

$

14.60

 

 

$

41,101

 

 

 

7.5

 

Vested and exercisable at September 30, 2019

 

 

9,412,266

 

 

$

14.86

 

 

$

21,157

 

 

 

6.6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The following is a summary of restricted stock awards for the current year period:

 

 

Restricted Stock Awards

 

 

 

Number of

Shares

 

 

Weighted

Average

Grant-Date Fair

Value

 

 

Weighted

Average

Remaining

Contractual

Term

(in years)

 

Unvested at December 31, 2018

 

 

 

 

$

 

 

 

0.0

 

Granted

 

 

299,798

 

 

$

18.30

 

 

 

 

 

Unvested at September 30, 2019

 

 

299,798

 

 

$

18.30

 

 

 

2.5

 

 

The following is a summary of restricted stock units for the current year period:

 

 

Restricted Stock Units

 

 

 

Number of

Shares

 

 

Weighted

Average

Grant-Date Fair

Value

 

 

Weighted

Average

Remaining

Contractual

Term

(in years)

 

Unvested at December 31, 2018

 

 

5,752,046

 

 

$

12.77

 

 

 

1.2

 

Granted

 

 

5,449,311

 

 

$

15.01

 

 

 

 

 

Vested

 

 

(2,859,765

)

 

$

12.93

 

 

 

 

 

Forfeited

 

 

(1,147,189

)

 

$

13.42

 

 

 

 

 

Unvested at September 30, 2019

 

 

7,194,403

 

 

$

14.30

 

 

 

2.2

 

 

Fair Value of Stock Options

The Company used the Black-Scholes-Merton option pricing model to estimate the fair value of stock options granted using the following assumptions:

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

2019

 

2018

 

2019

 

2018

Expected life (in years)

 

5.2 to 6.1

 

5.8 to 6.0

 

5.2 to 6.1

 

5.8 to 6.0

Risk-free interest rate

 

1.5% - 1.6%

 

2.8% - 3.0%

 

1.5% - 2.5%

 

2.7% - 3.0%

Volatility

 

44% - 45%

 

44% - 60%

 

44% - 46%

 

43% - 60%

Dividend yield

 

—%

 

—%

 

—%

 

—%

Fair value of common stock

 

$18.11 to $18.41

 

$12.00 to $13.65

 

$12.35 to $18.41

 

$12.00 to $13.65

 

2018 Employee Stock Purchase Plan, As Amended

The Company sponsors the ESPP that allows employees to purchase shares of common stock at a discounted price from the fair market value of Company’s common stock at each purchase date. Except for the initial offering period, the ESPP provides for 24-month offering periods beginning May 22 and November 22 of each year, and each offering period will consist of four six-month purchase periods. The initial offering period began on September 25, 2018 and will end on November 22, 2020. On each purchase date, eligible employees will purchase the shares at a price per share equal to 85% of the lesser of (1) the fair market value of the Company’s common stock on the offering date, or (2) the fair market value of its common stock on the purchase date. During the nine months ended September 30, 2019, the Company’s employees purchased 260,991 shares of its common stock under the ESPP at a weighted average purchase price of $10.20 with proceeds of $2.7 million. As of September 30, 2019, 2,412,453 shares of common stock remain available for grant under the ESPP.

 

The Company used the Black-Scholes-Merton option pricing model to estimate the fair value of ESPP purchase rights granted using the following assumptions:

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

2019

 

2018

 

2019

 

2018

Expected life (in years)

 

n/a

 

n/a

 

0.5 to 2.0

 

n/a

Risk-free interest rate

 

n/a

 

n/a

 

2.1% - 2.4%

 

n/a

Volatility

 

n/a

 

n/a

 

40% - 45%

 

n/a

Dividend yield

 

n/a

 

n/a

 

—%

 

n/a

Fair value of common stock

 

n/a

 

n/a

 

$16.98

 

n/a

 

Stock-Based Compensation Expense

Stock-based compensation expense recognized in the condensed consolidated financial statements is as follows:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

(in thousands)

 

2019

 

 

2018

 

 

2019

 

 

2018

 

Cost of revenue

 

$

718

 

 

$

6,472

 

 

$

2,805

 

 

$

7,776

 

Research and development

 

 

5,468

 

 

 

37,490

 

 

 

15,863

 

 

 

43,903

 

Sales and marketing

 

 

2,918

 

 

 

14,496

 

 

 

8,714

 

 

 

16,411

 

General and administrative

 

 

5,678

 

 

 

40,354

 

 

 

17,665

 

 

 

48,014

 

Stock-based compensation expense, net of amounts capitalized

 

 

14,782

 

 

 

98,812

 

 

 

45,047

 

 

 

116,104

 

Capitalized stock-based compensation expense

 

 

858

 

 

 

495

 

 

 

2,889

 

 

 

1,251

 

Stock-based compensation expense

 

$

15,640

 

 

$

99,307

 

 

$

47,936

 

 

$

117,355

 

 

As of September 30, 2019, unamortized stock-based compensation was as follows:

 

 

Unrecognized

stock-based

compensation

(in thousands)

 

 

Weighted

average

vesting

period

(in years)

 

Stock options

 

$

39,378

 

 

 

2.3

 

Restricted stock awards

 

 

4,575

 

 

 

2.5

 

Restricted stock units (service-based)

 

 

65,870

 

 

 

2.9

 

Restricted stock units (performance-based)(1)

 

 

9,260

 

 

 

1.2

 

ESPP

 

 

3,428

 

 

 

1.3

 

Total unrecognized stock-based compensation

 

$

122,511

 

 

 

 

 

 

(1)

The Performance Vesting Condition occurred upon the effectiveness of the registration statement for the Company's IPO, which was September 25, 2018. The remaining unrecognized stock-based compensation expense is recognized on an accelerated basis over the weighted-average remaining requisite service period.

 

 

 

 

 

 

 

 

401(k) Plan

In the United States, the Company offers its employees a defined contribution plan that qualifies as a deferred salary arrangement under Section 401 of the U.S. Internal Revenue Code (“401(k) Plan”). Under the 401(k) Plan, participating employees may defer a portion of their pretax earnings not to exceed the maximum amount allowed by the Internal Revenue Service. The Company currently provides a matching contribution of 25% of deferrals for eligible employees. Compensation expense for the Company's matching contributions was $0.7 million and $2.3 million during the three and nine months ended September 30, 2019, respectively, and $0.5 million and $1.8 million during the three and nine months ended September 30, 2018, respectively.